In This Issue
Linezolid approval brings new treatment option for resistant bacteria
Light-activated agent approved for ocular disorder
Clopidogrel linked to thrombotic thrombocytopenic purpura
Investigational program announced for continued cisapride access
USP adopts evidence-based criteria for botanicals
DOD, IOM find few significant adverse effects from anthrax vaccine
Meloxicam enters competitive NSAID market
FDA approves new cholinesterase inhibitor for Alzheimer's disease
Medicaid 'best price' provisions fall short, official testifies at hearing on Medicare drug benefit
Automation, leadership, open discussion needed to combat medical error
News Briefs
Inspiring patients to meet their treatment goals
Pharmacists and their resources
Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices
Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion
Investigating patient experiences after a formulary change
ASHP Practitioner Recognition Program-2000 Fellows of the American Society of Health-System Pharmacists
Roster of residents completing ASHP-accredited programs in calendar year 2000
Detecting and preventing health care fraud and abuse-we've only just begun
Career Opportunities